Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study.

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Abstract Text:

ABSTRACT Background: Previous studies have suggested that women with cardiovascular disease may receive less aggressive care than men. Using a large cardiology database from a tertiary referral center, we sought to determine if treatment differences still persist in the current era. Methods: We analyzed data on 2462 patients who were referred for secondary prevention to the Preventive Cardiology Clinic at The Cleveland Clinic Foundation between 1997 and 2004. The primary objective was to evaluate use of effective secondary preventive therapies, by gender, as outlined in the ACC/AHA guidelines, such as antiplatelet therapy, beta-blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors. Multivariate logistic regression analysis was performed to assess the independent effect of gender on all cause mortality. Results: Women were older (62.2 +/- 11.1 vs. 59.4 +/- 11.0, p < 0.001) and more likely to be hypertensive (68.1% vs. 56.1%, p < 0.001) than men. Overall, women were more likely than men to have higher baseline C-reactive protein (CRP) (6.14 +/- 13.4 vs. 4.9 +/- 10.7, p < 0.001), low-density lipoprotein cholesterol (LDL-C) (135 +/- 66 vs. 116 +/- 46, p < 0.001), high-density lipoprotein cholesterol (HDL-C) (52 +/- 17 vs. 41 +/- 11, p < 0.001), and total cholesterol (238 +/- 98 vs. 202 +/- 65, p < 0.001). Women were less likely to be on antiplatelet therapy (76.6 % vs. 85.0%, p < 0.001) and statins or any lipid-lowering therapy (62.6% vs. 67.1%, p = 0.04) compared with men on presentation. Conclusions: Even in the current era, women with established cardiovascular disease continue to receive less aggressive care than men. They are less likely to be on aspirin and statin therapy. More aggressive efforts should be made to treat both men and women with standard secondary preventive efforts.

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of women's health (2002)

VOLUME: 17

Page Numbers: 515-21

Journal Abbreviation:

ISSN: 1540-9996

DAY: 1

MONTH: May

YEAR: 2008

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101159262

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study.

AFFILIATION: Cleveland Clinic, Cleveland, Ohio.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Womens Health (Larchmt)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study Related Publications

• Activation of antifungal extracts of actinomycetes by ultrafiltration through gradocol membranes.
• Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study.
• Carbamazepine induces mitotic arrest in mammalian Vero cells.
• Characterization of oxidative pathways in chronic rhinosinusitis and sinonasal polyposis.
• Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages.
• Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36.
• Corrigendum: The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.
• Corrigendum: The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.
• Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
• Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
• Gender differences in utilization of effective cardiovascular secondary prevention: a cleveland clinic prevention database study.
• Glutamate surface speciation on amorphous titanium dioxide and hydrous ferric oxide.
• Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration.
• In vitro assessment of the cytotoxic and mutagenic potential of perfluorooctanoic acid.
• Indices for the measurement of gingival inflammation in clinical studies of oral hygiene and periodontal disease.
• Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
• Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells.
• Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity.
• Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo.
• Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.
• Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
• Relation of keratosis seborrheica and keratosis senilis to vitamin A deficiency.
• Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk.
• Rocky Mountain Spotted Fever in New York State Outside of New York City.
• Scrubbing Reimbursement Rates clean.
• The distribution of soil microorganisms antagonistic to fungi pathogenic for man.
• The lipid whisker model of the structure of oxidized cell membranes.
• The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.
• What cancer control dollars did in 1947 in Indiana.
• [OBJECTIVES OF THE DESIGNS FOR WATER SUPPLY SYSTEMS.]